Skip to main content
Erschienen in: World Journal of Surgery 8/2018

05.02.2018 | Original Scientific Report

Acute Limb Ischemia Secondary to Native Artery Occlusion: Results of a Contemporary Case Series

verfasst von: Nuria Seguí, Carlos Ruiz-Carmona, Alina Velescu, Eduardo Mateos, Roberto Elosua, Albert Clará

Erschienen in: World Journal of Surgery | Ausgabe 8/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

The treatment of acute limb ischemia (ALI) has barely changed over the last years. However, the progressive implementation of anticoagulants, antiplatelet agents or statins within the population might have modified the profile and prognosis of patients suffering an ALI. The aim of this study was to evaluate the current results of the management of ALI secondary to a native artery occlusion.

Methods

Retrospective study of 220 consecutive patients (mean age 78 years; 49% male) was conducted between 2007 and 2015. ALI secondary to trauma or grafts/stents occlusions were excluded. Statistical analysis was performed with logistic regression.

Results

A total of 141 cases (64.1%) were attributed to embolism and 79 (35.9%) to acute arterial thrombosis. Peripheral neuro-ischemic impairment occurred in 135 patients (61.4%), being severe in 42 (19.1%). ALI treatment included anticoagulation (n = 27; 12.3%), regional fibrinolysis (n = 2; 1%), embolectomy/thrombectomy (n = 129; 58.6%), angioplasty/stenting (n = 8; 3.6%), bypass (n = 47; 21.3%) or direct major limb amputation (n = 7; 3.2%). Limb salvage and survival rates at 30/90 days were 95%/95% and 82.3%/74.1%, respectively. Independent risk factors for major amputation were diabetes, severe neuro-ischemic impairment, acute arterial thrombosis and treatment delay >1 day after vascular consultation. In addition, age, chronic peripheral arterial disease, any neuro-ischemic impairment and a hospitalization for any other reason simultaneous to the ALI were independently associated with mortality.

Conclusions

Regardless of excellent limb salvage rates, patients currently suffering from an ALI are, when compared to previous studies, older than before and with an increased rate of mortality. Risk factors do not appear to be modifiable once the ALI appears so prevention strategies should be aimed to avoid the episode.
Literatur
1.
Zurück zum Zitat Tosato F, Pilon F, Daniel D et al (2011) Surgery for acute lower limb ischemia in the elderly population: results of a comparative study. Ann Vasc Surg 25:947–953CrossRefPubMed Tosato F, Pilon F, Daniel D et al (2011) Surgery for acute lower limb ischemia in the elderly population: results of a comparative study. Ann Vasc Surg 25:947–953CrossRefPubMed
2.
Zurück zum Zitat Kashyap VS, Gilani R, Bena JF et al (2011) Endovascular therapy for acute limb ischemia. J Vasc Surg 53:340–346CrossRefPubMed Kashyap VS, Gilani R, Bena JF et al (2011) Endovascular therapy for acute limb ischemia. J Vasc Surg 53:340–346CrossRefPubMed
3.
Zurück zum Zitat Fagundes C, Fuchs FD, Fagundes A et al (2005) Prognostic factors for amputation or death in patients submitted to vascular surgery for acute limb ischemia. Vasc Health Risk Manag 1(4):345–359CrossRefPubMedPubMedCentral Fagundes C, Fuchs FD, Fagundes A et al (2005) Prognostic factors for amputation or death in patients submitted to vascular surgery for acute limb ischemia. Vasc Health Risk Manag 1(4):345–359CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Donato G, Setacci F, Sirignano P et al (2014) The combination of surgical embolectomy and endovascular techniques may improve outcomes of patients with acute lower limb ischemia. J Vasc Surg 59:729–736CrossRefPubMed Donato G, Setacci F, Sirignano P et al (2014) The combination of surgical embolectomy and endovascular techniques may improve outcomes of patients with acute lower limb ischemia. J Vasc Surg 59:729–736CrossRefPubMed
5.
Zurück zum Zitat Eliason JL, Wainess RM, Proctor MC et al (2003) A national and single institutional experience in the contemporary treatment of acute lower extremity ischemia. Ann Vasc Surg 238(3):382–389 Eliason JL, Wainess RM, Proctor MC et al (2003) A national and single institutional experience in the contemporary treatment of acute lower extremity ischemia. Ann Vasc Surg 238(3):382–389
6.
Zurück zum Zitat Ouriel K, Veith FJ, Sasahar AA (2016) A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolys or peripheral arterial sugery (TOPAS) investigators. N Engl J Med 338(16):1105–1111CrossRef Ouriel K, Veith FJ, Sasahar AA (2016) A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolys or peripheral arterial sugery (TOPAS) investigators. N Engl J Med 338(16):1105–1111CrossRef
7.
Zurück zum Zitat Berridge DC, Kessel DO, Robertson I (2013) Surgery versus thrombolysis for initial management of acute limb ischemia. Cochrane Database Syst Rev 6:Cd002784 Berridge DC, Kessel DO, Robertson I (2013) Surgery versus thrombolysis for initial management of acute limb ischemia. Cochrane Database Syst Rev 6:Cd002784
8.
Zurück zum Zitat Wang JC, Kim AH, Kashyap VS (2016) Open or endovascular revascularization for acute limb ischemia. J Vasc Surg 63(1):270–278CrossRefPubMed Wang JC, Kim AH, Kashyap VS (2016) Open or endovascular revascularization for acute limb ischemia. J Vasc Surg 63(1):270–278CrossRefPubMed
9.
Zurück zum Zitat Akhtar W, Reeves WC, Moyahed A (1998) Indications for anticoagulation in atrial fibrillation. Am Fam Physician 58(1):130–136PubMed Akhtar W, Reeves WC, Moyahed A (1998) Indications for anticoagulation in atrial fibrillation. Am Fam Physician 58(1):130–136PubMed
10.
Zurück zum Zitat Kamath S, Lio GY (2002) Atrial fibrillation in the elderly: anticoagulation strategies and indications in the very elderly. Am J Geriatr Cardiol 11(6):357–362CrossRefPubMed Kamath S, Lio GY (2002) Atrial fibrillation in the elderly: anticoagulation strategies and indications in the very elderly. Am J Geriatr Cardiol 11(6):357–362CrossRefPubMed
11.
Zurück zum Zitat Royo-Bordonada MA, Armario P, Lobos JM et al (2017) Spanish adaptation of the 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Clin Investig Arterioscler 29(2):69–85CrossRefPubMed Royo-Bordonada MA, Armario P, Lobos JM et al (2017) Spanish adaptation of the 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Clin Investig Arterioscler 29(2):69–85CrossRefPubMed
12.
Zurück zum Zitat Kempe K, Starr B, Stafford JM et al (2014) Results of surgical management of acute thromboembolic lower extremity ischemia. J Vasc Surg 60:702–707CrossRefPubMed Kempe K, Starr B, Stafford JM et al (2014) Results of surgical management of acute thromboembolic lower extremity ischemia. J Vasc Surg 60:702–707CrossRefPubMed
13.
Zurück zum Zitat Graor RA, Comerota AJ, Douville I et al (1994) Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Vasc Surg 229:251–268 Graor RA, Comerota AJ, Douville I et al (1994) Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Vasc Surg 229:251–268
14.
Zurück zum Zitat Ouriel K, Shortell CK, DeWeese JA et al (1994) A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia. J Vasc Surg 19:1021–1030CrossRefPubMed Ouriel K, Shortell CK, DeWeese JA et al (1994) A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia. J Vasc Surg 19:1021–1030CrossRefPubMed
15.
Zurück zum Zitat Taha AG, Byrne RM, Avgerinos ED et al (2015) Comparative effectiveness of endovascular versus surgical revascularization for acute lower extremity ischemia. J Vasc Surg 61:147–154CrossRefPubMed Taha AG, Byrne RM, Avgerinos ED et al (2015) Comparative effectiveness of endovascular versus surgical revascularization for acute lower extremity ischemia. J Vasc Surg 61:147–154CrossRefPubMed
16.
Zurück zum Zitat Londero LS, Norgaard B, Houlind K (2014) Patient delay is the main cause of treatment delay in acute limb ischemia: an investigation of pre- and in-hospital time delay. World J Emerg Surg 9:56CrossRefPubMedPubMedCentral Londero LS, Norgaard B, Houlind K (2014) Patient delay is the main cause of treatment delay in acute limb ischemia: an investigation of pre- and in-hospital time delay. World J Emerg Surg 9:56CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Earnshaw JJ, Whitman B, Foy C et al (2004) National Audit of Thrombolysis for Acute Leg Ischemia (NATALI): clinical factors associated with early outcome. J Vasc Surg 39:1018–1025CrossRefPubMed Earnshaw JJ, Whitman B, Foy C et al (2004) National Audit of Thrombolysis for Acute Leg Ischemia (NATALI): clinical factors associated with early outcome. J Vasc Surg 39:1018–1025CrossRefPubMed
18.
Zurück zum Zitat Genovese EA, Chaer RA, Taha AG et al (2016) Risk factors for long-term mortality and amputation after open and endovascular treatment of acute limb ischemia. Ann Vasc Surg 30:82–92CrossRefPubMed Genovese EA, Chaer RA, Taha AG et al (2016) Risk factors for long-term mortality and amputation after open and endovascular treatment of acute limb ischemia. Ann Vasc Surg 30:82–92CrossRefPubMed
19.
Zurück zum Zitat Byrne RM, Taha AG, Avgerinos E et al (2014) Contemporary outcomes of endovascular interventions of acute limb ischemia. J Vasc Surg 59:988–995CrossRefPubMed Byrne RM, Taha AG, Avgerinos E et al (2014) Contemporary outcomes of endovascular interventions of acute limb ischemia. J Vasc Surg 59:988–995CrossRefPubMed
Metadaten
Titel
Acute Limb Ischemia Secondary to Native Artery Occlusion: Results of a Contemporary Case Series
verfasst von
Nuria Seguí
Carlos Ruiz-Carmona
Alina Velescu
Eduardo Mateos
Roberto Elosua
Albert Clará
Publikationsdatum
05.02.2018
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 8/2018
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-018-4511-3

Weitere Artikel der Ausgabe 8/2018

World Journal of Surgery 8/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.